GlassScriptPhysician profile
Antonio Moretta
NPI 1427299387
$311,801.36
in general payments reported to CMS, 2019-2025
45 companies · $84K in 2025
The $84K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,409 · 2021: $12K · 2022: $49K · 2023: $56K · 2024: $91K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $88K · Consulting Fee: $73K · Travel and Lodging: $32K · Food and Beverage: $24K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $88,463.00 |
| Consulting Fee | $72,743.87 |
| Travel and Lodging | $31,671.49 |
| Food and Beverage | $24,246.14 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $94,795.36 | 2021-2025 | Affera Mapping System, Micra, Pulseselect |
| Biotronik INC. | $65,086.59 | 2020-2025 | Selectra, Solia, Amvia Edge |
| Medical Device Business Services, INC. | $48,997.45 | 2019-2025 | Carto 3 |
| Biosense Webster, INC. | $40,710.60 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Boston Scientific Corporation | $31,884.95 | 2019-2025 | Ingevity+, General - Brady, Emblem Mri S-Icd |
| Acutus Medical, INC. | $13,262.37 | 2020-2023 | |
| Abbott Laboratories | $5,929.40 | 2019-2025 | Aveir, Merlin@Home, Jot Dx |
| Cvrx, INC. | $4,064.64 | 2020-2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $1,090.80 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $872.09 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $723.76 | 2019-2025 | Lifevest |
| Elutia, INC. | $653.27 | 2019-2020 | |
| Amgen INC. | $316.05 | 2019-2025 | Repatha, Repatha |
| Cardiva Medical, INC. | $290.09 | 2020-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiofocus, INC. | $286.49 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Moretta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.